Skip to main content
Journal of Thyroid Research logoLink to Journal of Thyroid Research
. 2016 Jun 28;2016:2168046. doi: 10.1155/2016/2168046

Corrigendum to “How to Treat a Signal? Current Basis for RET-Genotype-Oriented Choice of Kinase Inhibitors for the Treatment of Medullary Thyroid Cancer”

Hugo Prazeres 1,2,3, Joana Torres 1, Fernando Rodrigues 4, Joana P Couto 1,3, João Vinagre 1,3,5, Manuel Sobrinho-Simões 1,3,6, Paula Soares 1,3,*
PMCID: PMC4940563  PMID: 27433368

In the article titled “How to Treat a Signal? Current Basis for RET-Genotype-Oriented Choice of Kinase Inhibitors for the Treatment of Medullary Thyroid Cancer” [1], the following sentence should be added to the “Acknowledgments” section: This work was also supported by FEDER funds through Programa Operacional Factores de Competitividade (COMPETE) (FCOMP-01-0124-FEDER 011267).

References

  • 1.Prazeres H., Torres J., Rodrigues F., et al. How to treat a signal? Current basis for RET-genotype-oriented choice of kinase inhibitors for the treatment of medullary thyroid cancer. Journal of Thyroid Research. 2011;2011:10. doi: 10.4061/2011/678357.678357 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Thyroid Research are provided here courtesy of Wiley

RESOURCES